文献速递创伤骨科骨质疏松与代谢性骨病

近期临床骨折患者在骨折联络服务中的合并症与用药情况

Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service.
PubMed 文献 · Osteoporos Int · 2017-11-23

这项横断面研究纳入1282例50-90岁近期骨折的骨折联络服务(FLS)患者,评估与骨相关和跌倒相关骨折风险(BRR和FRR)有关的合并症与用药。66%的患者至少有一种BRR和/或FRR,至少一种BRR及至少一种FRR均与年龄、BMI和骨折类型相关,而与性别或骨密度(BMD)无关。作者认为系统评估这些因素有助于在FLS照护中更深入地评估再骨折风险。

要点

  • 66%的FLS患者至少有一种BRR和/或FRR,53%有至少一种BRR,46%有至少一种FRR。
  • 至少一种BRR及至少一种FRR均与年龄、BMI和骨折类型相关,与性别或BMD无关。
  • 同时具有至少一种BRR和至少一种FRR与年龄、BMI和重大骨折显著相关。

核心结论

  • 与骨折风险增加相关的合并症和用药存在于三分之二就诊于FLS的患者中。
  • 同时具有BRR和FRR的患者比例随年龄、BMI和骨折严重程度显著增加。
  • 作者认为系统评估这些因素对FLS照护中更深入地评估再骨折风险很重要。

研究设计与样本

  • 横断面队列研究,纳入50-90岁近期骨折并就诊于FLS的患者1282例(72%为女性,年龄65±9岁)。
  • 合并症按ICD-10分类,用药按解剖治疗化学(ATC)分类,并进一步分为与BRR和FRR相关的类别。

主要发现

  • 1282例患者中,53%有至少一种BRR,46%有至少一种FRR,66%有至少一种BRR和/或FRR。
  • 至少一种BRR及至少一种FRR均与年龄、BMI和骨折类型相关,但与性别或BMD无关。
  • 仅BRR(约20%)或仅FRR(约10%)的患者比例在各年龄、性别、BMI、骨折类型和BMD间相似。
  • 同时具有至少一种BRR和至少一种FRR与年龄、BMI和重大骨折显著相关,与性别或BMD无关。

临床怎么用

  • 作者认为系统评估与骨折风险增加相关的合并症和用药,对FLS照护中更深入地评估再骨折风险很重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: In this cross-sectional study, two-thirds of Fracture Liaison Service (FLS) patients had comorbidities and medications associated with increased bone- or fall-related fracture risk. Bone-related and fall-related fracture risk (BRR and FRR) were associated with age and fracture type, but not with gender or BMD. Systematic evaluation of these factors leads to a more profound assessment in FLS care. INTRODUCTION: This study is a systematic evaluation of comorbidities and medications associated with increased fracture risk in patients aged 50-90 years with a recent fracture visiting the FLS. METHODS: In this cross-sectional cohort study, comorbidities were classified according to ICD-10 and medications according to the Anatomic Therapeutic Chemical (ATC) classification and further categorized into those associated BRR and FRR. RESULTS: Of 1282 patients (72% women; 65 ± 9 years), 53% had at least one BRR, 46% had at least one FRR, and 66% at least one BRR and/or FRR. At least one BRR, as well as at least one FRR were associated with age, BMI, and fracture type, but not with gender or BMD. The proportion of patients with only BRR (± 20%) or only FRR (± 10%) was similar among ages, gender, BMI, fracture type, and BMD. The combination of at least one BRR and at least one FRR was significantly associated with age, BMI, and major fractures, but not with gender or BMD. CONCLUSION: Comorbidities and medications associated with increased fracture risk are present in two-thirds of patients visiting the FLS. In addition, the proportion of patients having a combination of BRR and FRR increased significantly with age, BMI, and fracture severity. This indicates that systematic evaluation of these factors is important for a more profound assessment of subsequent fracture risk in FLS care.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Vranken L, Wyers CE, Van der Velde RY, et al. Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service. Osteoporos Int. 2017. PMID: 29170857. doi:10.1007/s00198-017-4290-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。